Posted by Michael Wonder on 02 Jun 2021
The economics of alternative payment models for pharmaceuticals
1 June 2021 - Pharmaceuticals are priced uniformly by convention, but vary in their degree of effectiveness for different disease indications.
As more high-cost therapies have launched, the demand for alternative payment models has been increasing in many advanced markets, despite their well-documented limitations and challenges to implementation.
